BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 15, 2002
View Archived Issues
Boehringer Ingelheim and Genetronics sign gene therapy research agreement
Read More
Serono and Pfizer to copromote Rebif in the U.S.
Read More
Phase III patient enrollment complete for histrelin implant
Read More
Cell-based gene therapy research collaboration announced
Read More
Dyax acquires exclusive rights to a newly discovered prostate cancer target
Read More
Another major launch for Alcon's prostaglandin analogue for glaucoma
Read More
Russian researchers investigate profile of himantane, a potential new agent for Parkinson's disease
Read More
MetaPhore's lead SOD mimetics effective in animal models of pain and asthma
Read More
Antiplatelet/antithrombotic efficacy demonstrated for P2Y12 receptor antagonists
Read More
Ligands for EAATs identified in series of 5-methylglutamate analogues
Read More
Positive effects on aggressive behavior and learning reported for NVP-SRA-880
Read More
Desired profile confirmed for humanized PRO-140
Read More
Novel factor Xa inhibitor and oral prodrug presented at IUPHAR 2002 by Kissei
Read More
Novel FTase inhibitors in early development at Janssen
Read More
Vertex presents new caspase inhibitors for use in cancer, etc.
Read More
New p38alpha kinase inhibitors emerge from Scios R&D
Read More
Pfizer presents prostaglandin EP4 agonists for bone disorders
Read More
Synthesis, biological evaluation and use of NK1 antagonists reported by Roche
Read More
Estrogen receptor modulators with wide therapeutic application designed by Merck team
Read More
UCB claims novel GABA-A antagonists with antiepileptic activity
Read More
Clinical data support once-daily emtricitabine for HIV infection
Read More
Chiron licenses hepatitis C targets to Abbott
Read More
MedImmune receives FluMist complete response letter
Read More
Amrad discontinues development of AM-365
Read More
Enzon to reacquire Oncaspar rights from Aventis
Read More
Actimid shows antitumor activity in multiple myeloma
Read More